SCHEMBL6535278

SCHEMBL6535278

Cc1onc(-c2ccc(-c3cscn3)cc2)c1-c1ccc(S(=O)(=O)NC(C(=O)c2ccc(Br)cc2)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.48
MT-CO2 P00403 3/20 0.48
NR4A2 P43354 1/20 0.46
PTGS1 P23219 4/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CA3 P07451 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41
ADRA2B P18089 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
SLC6A2 P23975 1/20 0.41
PDE4A P27815 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535276 0.77 PTGS2 (0.53) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL6514547 0.73 PTGS2 (0.64) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL6512506 0.72 PTGS2 (0.66) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL11925221 0.69 PTGS2 (0.75) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL5073588 0.68 PTGS2 (0.81) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL29223105 0.68 PTGS2 (0.69) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL5481289 0.68 PTGS2 (1.00) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL5074525 0.68 PTGS2 (0.69) PTGS2MT-CO2NR4A2PTGS1CA12
SCHEMBL7367464 0.67 MMP2 (0.47) CA12CA9CA14ALDH1A1MMP2
Water SCHEMBL5477391 0.67 PTGS2 (1.00) PTGS2MT-CO2NR4A2PTGS1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6727238-B2 CYCLOOXYGENASE INHIBITORS PFIZER INC. 2004-04-27 US disclosed